Tap any paragraph to write a margin note. Your notes collect in the Desk below the text and file under cases with @. The side-by-side margin rail opens on a larger screen.

§
Marginalia
Code · BILL · 116th Congress · S. 102 (Introduced in Senate) — To significantly lower prescription drug prices for patients in the United States by ending government-granted monopo... · Sec. 7

Sec. 7. Prohibition of anticompetitive behavior

54 words·~1 min read·/bill/116/s/102/is/section-7

A research copy — for the controlling text, always check the official state or federal source. Not legal advice.

No manufacturer may engage in anticompetitive behavior violating section 5(a) of the Federal Trade Commission Act ( 15 U.S.C. 45(a) ) with another manufacturer that may interfere with the issuance and implementation of open, non-exclusive licenses under this Act or otherwise run contrary to the public interest in the availability of affordable prescription drugs.
Connectionstraces to 1
Citation graph
cites case law
Sec. 7
Prohibition of anticompetitive behavior
U.S.C.§ 45
Cites 1Cited by 0 across 0 sources
★   the supreme law of the land   ★
Don't Tread on Me
E Pluribus Unum — out of many, one

"If you don't know your rights, you don't have any."

Marginalia · a citizen's law index
A research desk, not legal advice. Always read the cited source before relying on a summary.
Questions or an issue? support@self-law.org
disclaimerMarginalia is a research index, not a law firm. Nothing on this site is legal, tax, or financial advice and no attorney–client relationship is formed by using it. Statutes, regulations, and case law change; summaries, search results, AI output, and member posts may be incomplete, out of date, or wrong. Any interpretation drawn from material on this site should be validated by a licensed attorney in your jurisdiction before you act on it.